Browse All

Current Filters

CLEAR FILTER x

TITLE

Long-Term Quality of Life in Patients With Focal Seizures Treated With ESL: Pooled Analysis From 3 Phase III Open-Label Extension Studies

Author:Cantu, David   Krishnaiengar, Suparna   Thomases, Daniel   Mehta, Darshan   Hall, Diane   Zhang, Yi   Gama, Helena   Pereira, Ana   Grinnell, Todd   

Session Name:P11: Epilepsy/Clinical Neurophysiology (EEG): ASMs Clinical Trial 1  

Topic:Epilepsy/Clinical Neurophysiology (EEG)  

Program Number:P11.009  

Author Institution:Sunovion Pharmaceuticals Inc. , Fort Lee, NJ  University of Florida, Jacksonville, FL  Sunovion Pharmaceuticals Inc. , Battle Ground, WA  Sunovion Pharmaceuticals Inc. , Marlborough, MA  Bial-Portela & C S.A., Coronado (S. Romão e S. Mamede), Portugal  

Safety of opicapone after 5 years of post-marketing experience worldwide

Author:Guedes, Luis   Graça, Joana   Sampaio, Maria   Vieira, Mariana   Rocha, Francisco   Gama, Helena   

Session Name:P14: Movement Disorders: Non Surgical Therapeutics in Parkinson's Disease 2  

Topic:Movement Disorders  

Program Number:P14.013  

Author Institution:BIAL – Portela & Cª., S.A., Coronado, Portugal